title: [Therapeutic potential of DPP-IV inhibitor for the treatment of Type 2 diabetes].
authors.affiliation: n-yasuda@hhc.eisai.co.jp
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Yasuda
authors.forename: Kazuto
authors.initials: K
authors.lastname: Yamazaki
authors.forename: Takashi
authors.initials: T
authors.lastname: Inoue
authors.forename: Tadashi
authors.initials: T
authors.lastname: Nagakura
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4 / Q000032:analysis; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D006801:Humans; D009570:Nitriles / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000378:metabolism; D011498:Protein Precursors / Q000378:metabolism; D011759:Pyrrolidines / Q000627:therapeutic use*
chemical_list: C121834:1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine; D009570:Nitriles; D010446:Peptide Fragments; D011498:Protein Precursors; D011759:Pyrrolidines; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D018819:Dipeptidyl Peptidase 4